ChewingGumImagerMartialBACQUETViaWikimediaCommons

Cannabis Chewing Gum for Multiple Sclerosis in Development

AXIM Biotechnologies and its partner Quay Pharmaceuticals have obtained the necessary licenses to move forward with the development of a cannabis chewing gum, called MedChew Rx, for the treatment of multiple sclerosis (MS).  

MedChew Rx is being developed as a pharmaceutical drug to treat pain and spasticity associated with MS, according to a press release.

The gum consists of 5 mg of cannabidiol (CBD) and 5 mg of tetrahydrocannabinol (THC).

Read More at SpecialtyPharmacyTimes.com

Categories
EntrepreneurshipInnovationInvestmentsMedicalNewsfeed
Tagged
AXIM Biotechnologiescannabis entrepreneurcannabis entrepreneursentrepreneurshipmarijuana as treatment for multiple sclerosismedical cananbisMedical Marijuanamedical marijuana and pharmaceutical sectormedical marijuana entering pharmaceuticalsmultiple sclerosispharmaceuticalsQuay Pharmaceuticalstreating multiple sclerosis with medical marijuana

Subscribe to Our Post Alerts

We keep your data private and do not share your information with anyone.

Good SEO Starts Here

Most Popular

Jetpack plugin with Stats module needs to be enabled.
Jetpack plugin with Stats module needs to be enabled.
Jetpack plugin with Stats module needs to be enabled.
Jetpack plugin with Stats module needs to be enabled.

Blunt Newswire

UPCOMING EVENTS

There are no upcoming events.

More Upcoming Events

Cannabis Jobs

Back to Top

Blunt: Curating the Cannabis Content you Need the Most

SIGN UP FOR FREE POST ALERTS!

We keep your data private and do not share your information with anyone.